TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Preventing Infusion-Related Reactions With Intravenous Amivantamab-Results From SKIPPirr, a Phase 2 Study: A Brief Report.

Alexander I Spira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.